Patents by Inventor Larry M. Weisenthal

Larry M. Weisenthal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8623613
    Abstract: Stains that are specific for calcium ion are used to assess and predict the effects of various treatments on the viability of cell types contained in a sample, wherein said stain detects endothelial cells that have massive calcium accumulation death.
    Type: Grant
    Filed: April 13, 2011
    Date of Patent: January 7, 2014
    Inventor: Larry M. Weisenthal
  • Patent number: 8192949
    Abstract: Microaggregates which mimic the native environment of cells contained in biopsied tissue are used to assess and predict the effects of various treatments on the viability of cell types contained in the microaggregate.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: June 5, 2012
    Inventor: Larry M. Weisenthal
  • Publication number: 20110275115
    Abstract: Stains that are specific for calcium ion are used to assess and predict the effects of various treatments on the viability of cell types contained in a sample, wherein said stain detects endothelial cells that have massive calcium accumulation death.
    Type: Application
    Filed: April 13, 2011
    Publication date: November 10, 2011
    Inventor: Larry M. WEISENTHAL
  • Patent number: 5149527
    Abstract: Immunopotentiating compositions which are useful in causing tumor necrosis and/or regression in subjects who have previously received successful therapy which destroys tumors and stimulates cytotoxic macrophages are described. The immunopotentiators are administered at a time when formation of macrophages specifically cytotoxic for the tumor have been generated by previous therapy.
    Type: Grant
    Filed: September 18, 1990
    Date of Patent: September 22, 1992
    Assignee: Oncotech, Inc.
    Inventor: Larry M. Weisenthal
  • Patent number: 4996145
    Abstract: A method for detecting the sensitivity of tumor cells to immune effector substances by using an assay that distinguishes living tumor cells from dead cells in mixed populations of cells. Acquired resistance to immune effectors used in therapy may be determined and used to identify methods to circumvent such resistance using the method.
    Type: Grant
    Filed: October 27, 1987
    Date of Patent: February 26, 1991
    Assignee: Oncotech Incorporated
    Inventor: Larry M. Weisenthal